0
0

Department of Veterans Affairs Awarded a Contract to NOVARTIS PHARMACEUTICALS CORPORATION for $2,635,334.24

Signed on

2/7/2025, 12:00 AM

NOVARTIS PHARMACEUTICALS CORPORATION Government Contract #36C25725N0190

NOVARTIS PHARMACEUTICALS CORPORATION was awarded a contract with the United States Government for $2,635,334.24. The contract was awarded by the agency office 257-NETWORK CONTRACT OFFICE 17 (36C257), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Novartis Pharmaceuticals Corporation. The contract is for the delivery of Lutathera & Pluvicto drugs and biologicals, funded by the Department of Veterans Affairs, with a total value of $2,635,334.24. Notable transactions include a payment of $4,106,391.52 and a deduction of $1,471,057.28 related to the contract.

Contract Details

Contract ID36C25725N0190
Contract TypeC
Total Obligation$2,635,334.24
Exercised Options$2,635,334.24
Base Amount + Options$2,635,334.24
Date Signed2025-02-07
Contract DescriptionLUTATHERA & PLUVICTO
Start Date2025-02-07
End Date2026-02-06

Agency Details

Awarding AgencyDepartment of Veterans Affairs
Awarding Sub AgencyDepartment of Veterans Affairs
Awarding Office257-NETWORK CONTRACT OFFICE 17 (36C257)
Funding AgencyDepartment of Veterans Affairs
Funding Sub AgencyDepartment of Veterans Affairs
Funding Office549-DALLAS (00549)

Recipient Details

RecipientNOVARTIS PHARMACEUTICALS CORPORATION
Recipient Location59 ROUTE 10 EAST HANOVER NEW JERSEY, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #P00001$-1,471,057.28March 24, 2026

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $-1,471,057.28 to NOVARTIS PHARMACEUTICALS CORPORATION. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #0$4,106,391.52February 7, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $4,106,391.52 to NOVARTIS PHARMACEUTICALS CORPORATION. The payment included a Subsidy Cost of $0.00.

Latest Bills

Save Our Shrimpers Act
Bill HR 2071May 14, 2026
Combating Organized Retail Crime Act of 2025
Bill HR 2853May 14, 2026
Made in America Manufacturing Finance Act
Bill HR 3174May 14, 2026
Advancing the Mentor-Protégé Program for Small Financial Institutions Act
Bill HR 3709May 14, 2026
A resolution withholding the pay of Senators if a Government shutdown occurs.
Bill SRES 526May 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2024-03: Unlawful and Unenforceable Contract Terms and Conditions".
Bill SJRES 128May 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "The Fair Credit Reporting Act's Limited Preemption of State Laws".
Bill SJRES 129May 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; File Disclosure".
Bill SJRES 127May 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Truth in Lending (Regulation Z); Use of Digital User Accounts to Access Buy Now, Pay Later Loans".
Bill SJRES 134May 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Debt Collection Practices Act (Regulation F); Time-Barred Debt".
Bill SJRES 126May 14, 2026